SAWAI GROUP HOLDINGS Co.,Ltd. (4887.T) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenJPY 1,654.50

From 52W high−31.48%

Volume1.91M

Market capJPY 191.88B

P/E (TTM)22.0x

P/S (TTM)0.9x

Div yield3.31%

Key dataSep 18, 2026

Open

JPY 1,654.50

From 52W high

−31.48%

Volume

1.91M

Market cap

JPY 191.88B

ValuationView details →

P/E (Fwd)

13.1x

EV/EBITDA

13.2x

P/E (TTM)

22.0x

RSI (14)

54.6

MomentumView details →

1D Return

+2.18%

YTD Return

−30.52%

ValuationView details →

P/E (Fwd)

13.1x

P/E (TTM)

22.0x

EV/EBITDA

13.2x

EV/Sales

1.4x

P/S (TTM)

0.9x

P/B (TTM)

0.9x

ProfitabilityView details →

Gross Margin

28.08%

Net Margin

−1.36%

EBITDA Margin

9.61%

ROE (TTM)

−1.53%

ROA (TTM)

−0.73%

Asset Turnover

0.55x

GrowthView details →

Revenue YoY

+9.06%

EPS YoY

—

FCF YoY

+537.62%

Revenue CAGR 3Y

−0.83%

EPS CAGR 3Y

−42.23%

EBITDA YoY

—

MomentumView details →

1D Return

+2.18%

YTD Return

−30.52%

1Y Return

−19.32%

RSI (14)

54.6

vs 50D SMA

+0.35%

vs 200D SMA

−17.81%

Capital & dividendView details →

Debt/Equity

0.69x

Current Ratio

2.25x

Quick Ratio

1.08x

Div Yield

3.31%

Div Rate

—

Div Growth 1Y

+0.00%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

200.68B

Net Income (TTM)

−2.74B

Op. CF (TTM)

20.29B

Next earningsNov 6, 2026 →

Latest newsMore news →

Sawai Pharmaceutical and Towa Pharmaceutical, the two major generic drugmakers under Sawai Group Holdings, are increasing production and supply of the anti-influenza generic oseltamivir in response to an unusually early flu season.3d ago

Sawai Pharmaceutical, under Sawai Group Holdings, will discontinue 46 generic drug products as inventory runs out, including 39 due to a major product portfolio restructuring to improve production efficiency and ensure stable supply of generics.45d ago

Similar companies

TOWA PHARMACEUTICAL CO.,LTD.4553.T KISSEI PHARMACEUTICAL CO.,LTD.4547.T Oncolys BioPharma Inc.4588.T GNI Group Ltd.2160.T Nippon Shinyaku Co.,Ltd.4516.T KAKEN PHARMACEUTICAL CO.,LTD.4521.T Find similar companies →

Latest newsMore news →

Sawai Pharmaceutical and Towa Pharmaceutical, the two major generic drugmakers under Sawai Group Holdings, are increasing production and supply of the anti-influenza generic oseltamivir in response to an unusually early flu season.3d ago Sawai Pharmaceutical, under Sawai Group Holdings, will discontinue 46 generic drug products as inventory runs out, including 39 due to a major product portfolio restructuring to improve production efficiency and ensure stable supply of generics.45d ago